Literature DB >> 29173152

Lipid-based Nanosized Delivery Systems for Fluoroquinolones: a Review.

Pio Maria Furneri1, Virginia Fuochi1, Rosario Pignatello2.   

Abstract

BACKGROUND: The class of fluoroquinolone antibiotics, due to its core chemical modifications, is considered as wide-spectrum antibacterial drugs with useful pharmacokinetic and pharmacodynamic properties. However, because of their poor solubility in water, they are used as salts (lactates or hydrochlorides). Fluoroquinolones, bacterial membranes and eukaryotic cell membranes interactions are well known and their permeation properties are well investigated. In fact, they are concentrated inside the cells and intracellular compartments. Nanotechnology in Drug Delivery has developed many supra-molecular structures that have been used to improve both pharmacokinetic and pharmacodynamic properties. The main results of the published papers showed reduction of toxicity, higher intracellular concentrations (both bacteria and eukaryotic), enhancement of antimicrobial activity, prolonged drug release, decreased mortality in animal model studies, improved water solubility and improved in vitro efficacy against intracellular pathogens.
METHODS: a literature search was performed in the NCBI-PUBMED database, with no time range, using the keywords "solid lipid nanoparticles" and 'quinolones' or the name of single antibiotics.
RESULTS: the most important aspects of lipid-based nanocarrier technology used for fluoroquinolones have been highlighted, with a focus on the latest formulation developments that have led to significant improvements of pharmacokinetics and pharmacodynamics. Both technological and microbiological aspects of published papers have been discussed.
CONCLUSION: the potentiality of using lipid nanoparticles to improve the efficacy and potency of quinolone antibiotics has been supported by recent scientific publications, although some criticism appeared due to the microbiological investigative methods used and because of lack of systematic evaluation about the influence of technological approaches to the in vitro and in vivo drug activity. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Lipid nanocarriers; NLC; SLN; ciprofloxacin; enrofloxacin; gatifloxacin; levofloxacinzzm321990; norfloxacin; ofloxacin; quinolone

Year:  2017        PMID: 29173152     DOI: 10.2174/1381612823666171122110103

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

Review 1.  Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.

Authors:  Amjed Alabresm; Savannah L Chandler; Brian C Benicewicz; Alan W Decho
Journal:  Bioconjug Chem       Date:  2021-07-28       Impact factor: 4.774

2.  A Method for Efficient Loading of Ciprofloxacin Hydrochloride in Cationic Solid Lipid Nanoparticles: Formulation and Microbiological Evaluation.

Authors:  Rosario Pignatello; Antonio Leonardi; Virginia Fuochi; Giulio Petronio Petronio; Antonio S Greco; Pio Maria Furneri
Journal:  Nanomaterials (Basel)       Date:  2018-05-06       Impact factor: 5.076

3.  Effective targeted therapy for drug-resistant infection by ICAM-1 antibody-conjugated TPGS modified β-Ga2O3:Cr3+ nanoparticles.

Authors:  Xu-Qi Kang; Gao-Feng Shu; Sai-Ping Jiang; Xiao-Lin Xu; Jing Qi; Fei-Yang Jin; Di Liu; Yong-Hong Xiao; Xiao-Yang Lu; Yong-Zhong Du
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

Review 4.  Engineered Nanotechnology: An Effective Therapeutic Platform for the Chronic Cutaneous Wound.

Authors:  Suhasini Mallick; Moupriya Nag; Dibyajit Lahiri; Soumya Pandit; Tanmay Sarkar; Siddhartha Pati; Nilesh Prakash Nirmal; Hisham Atan Edinur; Zulhisyam Abdul Kari; Muhammad Rajaei Ahmad Mohd Zain; Rina Rani Ray
Journal:  Nanomaterials (Basel)       Date:  2022-02-25       Impact factor: 5.076

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.